ARTOSI, Fabio et al. Tildrakizumab as a Potential Option for Early Psoriatic Arthritis in Patients with Metabolic Comorbidities and Psoriasis: a Case Series. Dermatology Practical & Conceptual, [S. l.], v. 15, n. 4, p. 5570, 2025. DOI: 10.5826/dpc.1504a5570. Disponível em: https://mail.dpcj.org/index.php/dpc/article/view/5570.. Acesso em: 9 may. 2026.